1. Introduction {#s0005}
===============

Failure to adaptively process emotional information is one of the major components of Major Depressive Disorder (MDD). Compromised capacity to adaptively appraise emotional stimuli may contribute to getting 'stuck in the rut', a recent reformulation of MDD as an inability to regulate the depressive state resulting from a tendency to engage in, and an inability to disengage from a negative mood state, instead of a disorder of a negative mood state *per se* ([@bb0005]). At the same time, anhedonia, a fundamental aspect of MDD, may in large part reflect an inability to engage in positive emotional appraisal and may further contribute to the inability to regulate the depressive state. Animal research and neuroimaging studies with humans indicate that adaptive appraisal of emotional stimuli and regulation of emotional states depends on intact interactions between (para)limbic and subcortical brain structures and dorsal and lateral prefrontal cortical (PFC) areas ([@bb0010; @bb0015; @bb0020]). A reduction in the coordinated engagement of such neural systems during emotional processing is one possible mechanism underlying MDD. The interconnections of regions involved in evaluation of potentially salient information and those involved in cognitive appraisal and top-down control may be particularly important for predicting the capacity of individuals to effectively regulate incoming emotional information and emotional states.

So far, functional magnetic resonance imaging (fMRI) studies that have specifically tested for the connectivity of (para)limbic and prefrontal regions in MDD have mainly used seed-based analysis approaches. These studies have suggested abnormal connectivity of the amygdala ([@bb0025; @bb0045; @bb0040; @bb0030; @bb0035]), thalamus ([@bb0025; @bb0040; @bb0030; @bb0035]), frontal regions ([@bb0060; @bb0035; @bb0055]) including the anterior cingulate cortex (ACC); ([@bb0025; @bb0045; @bb0030; @bb0035; @bb0055]) and parietal regions ([@bb0070; @bb0055; @bb0065]), during emotional paradigms ([@bb0025; @bb0040; @bb0060]) and without any externally cued task (the so called resting state; [@bb0070; @bb0030; @bb0075; @bb0035; @bb0055]). Although these studies support the hypothesis of abnormal (para)limbic--prefrontal connectivity in MDD, such approaches only allow to test for connectivity based upon a limited number of seed regions (e.g., the amygdala), potentially missing important information about more broadly interconnected regions throughout the brain.

In this study we tested whether MDD patients showed different patterns of connectivity in distributed networks during a controlled emotional processing task compared with controls and examined whether these differences were related to individual differences in the propensity to engage in positive and negative affective behavior. As choosing a seed region or set of seed-templates may be biased when the seed is based at least partially on the data being analyzed ([@bb0080]), a problem that is particularly pronounced in clinical fMRI studies that compare seed-based connectivity across groups, we used a set of completely independently-derived independent component networks (ICNs). These ICNs have been derived from a resting state study using healthy individuals ([@bb0085]) and show strong correspondence to a set of spatial components estimated in a meta-analysis of the BrainMap database, which consists of activation maps from nearly 30,000 subjects engaged in a wide variety of tasks ([@bb0090]). Our template ICNs therefore depict interconnected networks of brain regions that co-activate when particular categories of tasks or cognitive processes are being performed ([@bb0090]), including perception, motor processing, cognition, and emotional processing. We hypothesized that prefrontal and limbic connectivity with the template networks, specifically those found previously to become active during emotion tasks, would be reduced in a group of individuals with MDD compared to a sample of matched healthy controls.

2. Materials & methods {#s0020}
======================

2.1. Participants {#s0025}
-----------------

Twenty-five right-handed medication-free patients with a half-year diagnosis of MDD (16 female; age range: 20--52), with no past or present diagnosis of comorbid anxiety disorders were selected from the Netherlands Study of Depression and Anxiety (NESDA [@bb0095]; [Appendix A](#ec0005){ref-type="supplementary-material"}) neuroimaging study. Eighteen patients were medication naïve and seven patients reported to have used anti-depressive medication before participating to the NESDA but had already ceased taking medication on their own prior to enrolment. Three of the 7 patients who had previously used anti-depressive medication were medication free for at least 3 weeks before scanning and the remainder for at least 6 weeks. Diagnoses according to Diagnostic and Statistical Manual of Mental Disorders --- Fourth Edition (DSM-IV) algorithms were established using the structured Composite International Diagnostic Interview (CIDI; [@bb0100])-lifetime version 2.1, administered by a trained interviewer.

Twenty-five right-handed medication-free patients with a half-year diagnosis of MDD (16 female; age range: 20--52), with no past or present diagnosis of comorbid anxiety disorders were selected from the Netherlands Study of Depression and Anxiety (NESDA [@bb0095]; Appendix A) neuroimaging study. Eighteen patients were medication naïve and seven patients reported to have used anti-depressive medication before participating to the NESDA but had already ceased taking medication on their own prior to enrolment. Three of the 7 patients who had previously used anti-depressive medication were medication free for at least 3 weeks before scanning and the remainder for at least 6 weeks. Diagnoses according to Diagnostic and Statistical Manual of Mental Disorders --- Fourth Edition (DSM-IV) algorithms were established using the structured Composite International Diagnostic Interview (CIDI; [@bb0100])-lifetime version 2.1, administered by a trained interviewer.

The control group consisted of 25 age, sex, handedness, scan-center and education matched healthy control participants also recruited through NESDA, who were currently free of, and had never met criteria for depressive or anxiety disorders or any other axis-I disorder, and were not taking any psychotropic drugs. Exclusion for all participants in this analysis were: 1) a history of major internal or neurological disorder, 2) dependency or recent abuse (past year) of alcohol and/or drugs, 3) hypertension, 4) left handedness, 5) general MR-contraindications.

2.2. Task paradigm {#s0030}
------------------

We employed an event-related subject-paced word-classification paradigm ([@bb0105]), programmed in E-prime software ([@bb0110]). Forty positive, 40 negative, 40 neutral study words, and 40 baseline trials were presented in a pseudo-randomized order in 20 blocks of eight words. Each block consisted of two negative words, two positive words, two neutral words, and two control words. Words were matched for length (ranging from three to twelve letters) and frequency of use. The task was paced by the subject, but each word was presented with a maximum duration of 5 s. Subjects had to indicate whether they thought the word presented was positive, negative, or neutral to them (response options were displayed at the bottom of the screen). Control words were '≪left', '≪middle≫', and 'right≫' and participants were instructed to press the corresponding button. This task was part of a word recognition paradigm ([@bb0115]). Therefore, the task started and ended with three filler words to protect for the 'primacy--recency' memory effect.

2.3. Procedure {#s0035}
--------------

Patients and controls fulfilled an initial baseline measurement, which included establishment of diagnosis using the CIDI and a wide range of psychosocial measures including a demographic interview, current and life-time psychopathology interview, personal history information, current depressive and anxiety state questionnaires (including the Inventory of Depressive Symptomatology (IDS) ([@bb0120]) and Beck\'s Anxiety Inventory (BAI); [@bb0125]), and personality measures (NEO Five Factor Inventory \[NEO FII\]; [@bb0130]). After an average interval of eight weeks, patients and controls were included for the MRI session in one of the three participating centers, the Leiden University Medical Center (LUMC), Academic Medical Center (AMC) Amsterdam, or University Medical Center Groningen (UMCG). The Ethical Review Boards of each center approved this study. All participants provided written informed consent.

Severity of depression and anxiety on the day of scanning was again assessed using Dutch versions of the BAI ([@bb0125]) the Montgomery Åsberg Depression Rating Scale (MADRS; [@bb0135]), and the IDS ([@bb0120]). The word paradigm was performed as part of a larger functional imaging session ([@bb0145; @bb0140; @bb0115; @bb0150]).

2.4. Image acquisition {#s0040}
----------------------

Imaging data were acquired using Philips 3 T MR-systems (Best, The Netherlands) located at the LUMC, AMC, and UMCG, equipped with a SENSE-8 (LUMC and UMCG) and a SENSE-6 (AMC) channel head coil, respectively. For each subject, echo-planar images (EPI) were obtained using a T2\*-weighted gradient echo sequence (repetition time \[TR\] = 2300 ms, echo time \[TE\] = 30 ms \[UMCG: TE = 28 ms\], matrix size: 96 × 96 \[UMCG: 64 × 64\], 35 axial slices \[UMCG: 39 slices\], interleaved acquisition, 2.29 × 2.29 mm in-plane resolution \[UMCG: 3 × 3 mm\], 3 mm slice thickness). EPI\'s were scanned parallel to the anterior--posterior commissure plane. Scan session length was dependent on the subjects\' pace of completing the task (i.e. response time in classifying words and baseline assignments) and varied between 128 and 240 volumes (Mean = 166.3, SD = 20.6). Anatomical imaging included a sagittal 3D gradient-echo T1-weighted sequence (TR = 9 ms, TE = 3.5 ms; matrix 256 × 256; voxel size: 1 × 1 × 1 mm; 170 slices).

2.5. Statistical analysis {#s0045}
-------------------------

Imaging data acquired during the word-classification task were processed using FSL software (FMRIB\'s Software Library, [www.fmrib.ox.ac.uk/fsl](http://www.fmrib.ox.ac.uk/fsl){#ir0020}; [@bb0155]). Preprocessing of the fMRI images was carried out using FEAT (FMRI Expert Analysis Tool), implemented in MELODIC Version 3.10. The following processing steps were applied: motion correction, slice timing correction, non-brain removal, spatial smoothing using a Gaussian kernel of 5 mm full width at half minimum, grand-mean intensity normalization of the entire 4D dataset by a single multiplicative factor, high pass temporal filtering (Gaussian-weighted least-squares straight line fitting, with sigma = 150 s). Next, the functional images were registered to MNI-152 standard space (T1-standard brain averaged over 152 subjects; Montreal Neurological Institute, Montreal, QC, Canada) using a two-step registration from functional to high-resolution structural T1-image (rigid body, 6 degrees of freedom) to MNI-template (affine registration, 12 degrees of freedom). Normalized 4D datasets were resampled to 4 mm isotropic voxels, a voxel size slightly larger than the largest native voxel size from any of the datasets and matching preprocessing steps in previous work from our group ([@bb0150]).

Resampled and normalized datasets from both MDD patients and HCs were then entered into a dual regression analysis ([@bb0160; @bb0170; @bb0165]) using the set of eight standard independent component networks (ICNs) as described in detail in [@bb0085]. In the dual regression procedure, two stages of multiple linear regression analyses are performed. 1) A time series is estimated for each ICN template per subject, using the subject\'s functional data (normalized to unit variance) as the predicted variable and the set of spatial ICNs as predictors; 2) A subject-specific weighted spatial map is 'regressed' using the time series created in [@bb0005] as predictors of the participant\'s functional data. This dual regression analysis approach generates statistical maps that show the connectivity of a subject specific network to the template network of interest. These resulting spatial maps represent an unbiased measure of the degree to which BOLD signal fluctuations in each voxel covary with each ICN time series for each subject separately. More simply, each participant\'s spatial map for a given ICN can be considered a voxelwise map of the strength of functional connectivity with that ICN. The spatial maps can be used in voxelwise analysis to assess differences between groups in connectivity strength to the template ICN. The dual regression method following ICA has proven its sensitivity to detect connectivity differences following alcohol and morphine intake ([@bb0165]) and in young carriers of the APOE4 gene relative to non-carriers ([@bb0170]).

To assess main effects across both groups of functional connectivity within each ICN, individual spatial maps were included in a one-sample t-test performed separately for each ICN. To assess group differences in functional connectivity within each ICN, individual spatial maps were compared in a one-way ANOVA performed separately for each ICN, with scan site added as a covariate (coded as two dummy covariates). All results are reported at *p* \< .05, family wise error corrected for multiple comparisons using permutation tests (\# permutations = 5000) with cluster-mass thresholding (voxelwise threshold: t = 2.3; [@bb0175]). We exported significant clusters to SPSS to test for effects age, sex, illness severity and variations in personality scores related to tendencies to engage in positive or negative affect, extraversion and neuroticism, respectively. Scores were derived from the extraversion and neuroticism subscales of the NEO-FFI ([@bb0130]), that have shown strong correlations with positive affect and negative affect as measured with the Positive and Negative Affect Schedule (PANAS; [@bb0180]). Neuroticism has been defined as the tendency to experience negative emotions and psychological distress in response to negative/stressful events and has been strongly associated with MDD (r = .60) ([@bb0185]), whereas extraversion is thought to reflect the degree of positive emotionality, sociability, and approach related behavior ([@bb0190]) and has been negatively and uniquely associated with MDD (r = -.33) and social anxiety disorder (r = -.59), and not with other affective disorders ([@bb0185]).

3. Results {#s0010}
==========

3.1. Clinical characteristics and behavioral results {#s0050}
----------------------------------------------------

[Table 1](#t0005){ref-type="table"} lists sample characteristics and between group statistics. No site × diagnosis effects occurred (χ^2^ = 0, *p* = 1), and no systematic difference in clinical characteristics was observed between patients included at the different sites (IDS_T1: F~2,24~ = .83, *p* = .45; IDS_T2: F~2,24~ = .017, *p* = .98; MADRS_T2: F~2,24~ = 1.22, *p* = .32). No group difference was observed in the number of volumes acquired during the self-paced task (F~1,49~ = .69, *p* = .41).

MDD showed higher depression scores and anxiety scores, and higher scores on neuroticism, and agreeableness than controls, but lower scores on extraversion, and conscientiousness ([Table 1](#t0005){ref-type="table"}). Between the NESDA interview (T1) and the MRI-session (T2) depressive symptom ratings decreased in MDD (IDS, paired-sample t-test: t~24~ = 4.05,*p* = .001). At the time of scanning, eight MDD patients had IDS scores indicative of the remitted state. Within the MDD group, neuroticism correlated positively with IDS score both at T1 and T2, whereas IDS was inversely correlated with extraversion (IDS_T1 --- neuroticism: r = .63, *p* = .001; IDS_T2 --- neuroticism: r = .47, *p* = .03; IDS_T1 --- extraversion: r = − .55, *p* = .004; IDS_T2 --- extraversion: r = − .49, *p* = .03; all two-tailed). An interaction of valence classification and diagnosis was observed (F\[1,2; 57.66\] = 6.05, *p* = .013, *ŋ*^2^ = .11), resulting from the MDD patients indicating less words as 'positive' and more words as 'neutral' than controls. Within MDD neutral and positive word classification was unrelated to IDS scores, extraversion and neuroticism (r~kendall\'s\ tau~ \< \|.11\|, *p* \> .64). No main effect of diagnosis and no interaction of diagnosis × valence occurred on response times (F \< 2.05, *p* \> .14).

3.2. Functional connectivity results {#s0055}
------------------------------------

Overall, mean spatial maps over both groups (i.e., one-sample t-tests per component) closely matched the template ICNs, although the components often included additional regions compared with the templates (see [Appendix B](#ec0010){ref-type="supplementary-material"}).

Overall, mean spatial maps over both groups (i.e., one-sample t-tests per component) closely matched the template ICNs, although the components often included additional regions compared with the templates (see Appendix B).

Comparison of spatial maps between the two groups showed decreased connectivity in MDD compared to controls of bilateral medial PFC, nucleus accumbens, and right orbitofrontal cortex (OFC) extending into the caudate nucleus, with a template network comprising the ventrolateral-PFC, dorsolateral-PFC, ACC, medial-PFC, cerebellum, and cuneus ([Fig. 1](#f0005){ref-type="fig"}). This fronto-opercular template network had the strongest loading on emotion-related tasks in the BrainMap database ([@bb0090]) and has previously been described as the salience network ([@bb0195]). No significant between-group differences were observed for the other networks.

3.3. Effects of illness severity and affect {#s0060}
-------------------------------------------

We exported the individual beta-values of the total cluster and 8 sub-clusters to SPSS to test for possible confounds and relations with clinical variables and task behavior ([Table 2](#t0010){ref-type="table"}; the main cluster was separated into sub-clusters based on whether each voxel\'s six directly neighboring voxels were also correlated, thus allowing us to make sure in post hoc tests that results pertained to all anatomically discrete sub-regions of the larger cluster). A one-way MANOVA confirmed the voxel-wise analysis across all sub-clusters, with lower values in MDD than in controls (F\[8,41\] = 2.66, *p* = .019). Adding age, education, sex, history of medication use, and number of volumes did not change the result (F\[8,36\] = 2.43, *p* = .033). In a previous study, we reported on decreased gray matter in inferior frontal gyrus and rostral ACC (([@bb0200]), consistent with meta-analytic results of ([@bb0205])), both implicated in the salience network. However, volumetric difference could not account for the difference in connectivity with the salience network between MDD patients and controls, if anything making the group difference stronger (F\[8,34\] = 3.40, *p* = .006). Within MDD, connectivity of the whole medial PFC-striatal regions within the salience network was not explained by depression severity (IDS_T2: β = − .04, *p* = .86), change in IDS score between T1 and T2 (\[∆ IDS = (IDS_T1 − IDS_T2) / IDS_T1\]; β = .26, *p* = .23), or years since first episode (β = .36, *p* = .16) with age added to the model.

Within MDD, connectivity of the fronto-striatal areas with the salience network was positively predicted by extraversion scores (β~E~ = .4, *p* = .049, *R*^2^ = .16), an effect that became stronger when neuroticism (N) was added to the model (β~E~ = .64, *p* = .012; ∆*R*^2^ = .10, n.s.). Adding variations on other NEO-FFI scales (i.e. openness, conscientiousness, and agreeableness) and sex did not affect the predictive value of extraversion (β~E~ = .80, *p* = .008). Finally, we added depression severity scores at the time of scanning to the model (IDS_T2), but this left the results unchanged as well (β~E~ = .77, *p* = .014). Neuroticism did not predict abnormal connectivity in MDD (β~N~ = .002, *p* = .99, *R*^2^ \< .001); with extraversion added to the model: (β~N~ = .39, *p* = .11; ∆*R*^2^ = .25, *p* \< .05). Finally, connectivity of the total fronto-striatal cluster with the salience network was not predicted by word classification behavior (all β \< .13, *p* \> .55).

In healthy controls, extraversion and neuroticism were not predictive of fronto-striatal connectivity (β~E~ = − .26, *p* = .21, *R*^2^ = .07; with neuroticism added to the model: β~E~ = − .29, *p* = .20; ∆*R*^2^ = .005, n.s.; β~N~ = .03, *p* = .91, *R*^2^ = .001; with extraversion added to the model: β~N~ = − .08, *p* = .73, ∆*R*^2^ = .07, n.s.).

4. Discussion {#s0015}
=============

In this study we investigated whole-brain functional connectivity in MDD during execution of an emotional word evaluation task using a subset of eight independently derived independent component networks. Consistent with previous studies ([@bb0025; @bb0030]), we demonstrated decreased functional connectivity of the medial PFC, putamen, OFC, caudate nucleus, and ventral striatum (including the nucleus accumbens) with a fronto-opercular 'salience' network ([@bb0195]) in medication-free MDD as compared with healthy control participants. Results were unexplained by age, education, sex, and brain volume of regions implicated in the neuroanatomical profile of MDD. Moreover, within MDD, functional connectivity of the fronto-striatal regions was unrelated to illness severity, but positively related to extraversion scores, which are strongly related to the tendency to engage in behavior that enhances positive affect. No differences in functional connectivity were observed within any other network.

These results confirm the hypothesis that abnormal intrinsic connectivity of cortical and subcortical and (para)limbic regions during emotional processing is part of the functional pathophysiology of MDD. Our results indicate that decreased coupling of medial prefrontal and striatal regions with the salience network might not be a state phenomenon of MDD. Instead it appears as a phenomenon that continues into the (newly) remitted phase, possibly representing a dimension that does not correlate with clinical recovery as measured with standard depression severity measurements. This dimension may relate to the propensity to engage in positive emotions ([@bb0210]) and activities that promote social attention ([@bb0215]), as connectivity in these regions was found to be uniquely related to the personality trait extraversion. Therefore, decreased connectivity of the fronto-striatal regions with the salience network may represent a long-lasting or trait characteristic of diminished capacity to engage in positive events and thoughts in a manner that can enhance positive mood states.

Importantly, the decreased subcortical--cortical coupling was observed with the *salience* network, a network that has been found to specifically correlate with subjective emotional ratings ([@bb0195]). Furthermore, the salience network is the only network of the [@bb0090] study that showed a high load on emotional processes and tasks in a large scale meta-analysis of the BrainMap database ([@bb0090]), but also loads on sensory perception, including pain perception, working memory, explicit memory, cognition, and action inhibition ([@bb0090]). The fronto-opercular salience network mainly comprises the dorsal anterior cingulate cortex, bilateral ventral lateral prefrontal cortices, and bilateral insula. These regions have been associated with emotional conflict resolution ([@bb0220]), inhibitory control and mood regulatory processes ([@bb0225]), and the consciousness processing of affect ([@bb0230]). The insula is considered an important hub for processing salient events for action to be initiated, including calling on attentional resources (together with the anterior cingulate cortex) and regulating autonomic activity in reaction to salient stimuli ([@bb0235]). Disruption in this circuit therefore most likely leads to abnormalities in affective state regulation, and has previously been associated with MDD during rest ([@bb0030; @bb0245; @bb0240; @bb0055; @bb0150]).

Regions that were found to show abnormal connectivity with the salience network have been implicated in circuitry responsible for behavioral and affect regulation in neuropsychiatric disorders, including the anterior cingulate-, orbitofrontal-, and dorsolateral prefrontal circuitry ([@bb0250]). It has been suggested that the medial PFC may play an important role in moderating visceral processes related to emotions ([@bb0255]). The nucleus accumbens has been repeatedly associated with reward processing and impaired motivation ([@bb0250]). A failure to sustain activation in this region during up-regulation of positive emotional states has been linked to anhedonia in MDD patients ([@bb0260]). The medial OFC has been implicated in approach related behavior, reward anticipation, and fear-extinction ([@bb0265]), and has numerous projections to visceral-motor structures that are critical to modulate behavior and emotional expression ([@bb0265; @bb0270; @bb0255]). Previously, activation in the medial OFC was found to be positively correlated with extraversion during reward processing ([@bb0275]). Finally, the dorsolateral caudate nucleus and frontal pole have been implicated in a circuitry related to the integration of prefrontal and subcortical activity for executive control ([@bb0250]). Together, the present results indicate compromised functioning of a distributed network involved in behavioral modulation and -expression, and reward processing in MDD.

In this study, we included a well-characterized sample of right-handed, medication free MDD patients without any past or present comorbid psychopathology. Moreover, we used a new approach to study functional connectivity during the execution of an emotional word classification task. We used template ICNs to create subject specific component maps, based on the time series that best fit the weighted templates using the dual regression approach ([@bb0160]). These template components have been found to be highly consistent and have been independently detected in a number of populations (e.g., Alzheimer\'s disease ([@bb0280])), MDD ([@bb0150]), and healthy controls ([@bb0085]). Overall, use of the template ICNs and the dual regression approach resulted in highly consistent components across groups that strongly corresponded to the template ICNs ([Appendix B](#ec0010){ref-type="supplementary-material"}). The mean across-group ICNs also included some additional brain regions not in the template ICNs, possibly reflecting regions that show coupling with the template ICNs during the emotional word encoding task (as compared to the resting state), though such additional regions could also be the result of greater statistical sensitivity in the current sample and thus precludes an in-depth interpretation. A strength of the current approach is that it is not limited to standard fMRI task paradigms with associated restrictions on the timing and number of trials, but can be used to study sustained engagement of brain networks over the duration of a task involving multiple trials and even trial types. Another advantage is that the template-ICN dual regression method allows for the study of connectivity across groups and tasks in a standardized and unbiased way, which is crucial for studies involving comparisons between clinical and non-clinical samples. Using template ICNs should increase reproducibility of effects and comparability across studies, due to the independence of the ICN templates in reference to the data under study.

In this study, we included a well-characterized sample of right-handed, medication free MDD patients without any past or present comorbid psychopathology. Moreover, we used a new approach to study functional connectivity during the execution of an emotional word classification task. We used template ICNs to create subject specific component maps, based on the time series that best fit the weighted templates using the dual regression approach ([@bb0160]). These template components have been found to be highly consistent and have been independently detected in a number of populations (e.g., Alzheimer\'s disease ([@bb0280])), MDD ([@bb0150]), and healthy controls ([@bb0085]). Overall, use of the template ICNs and the dual regression approach resulted in highly consistent components across groups that strongly corresponded to the template ICNs (Appendix B). The mean across-group ICNs also included some additional brain regions not in the template ICNs, possibly reflecting regions that show coupling with the template ICNs during the emotional word encoding task (as compared to the resting state), though such additional regions could also be the result of greater statistical sensitivity in the current sample and thus precludes an in-depth interpretation. A strength of the current approach is that it is not limited to standard fMRI task paradigms with associated restrictions on the timing and number of trials, but can be used to study sustained engagement of brain networks over the duration of a task involving multiple trials and even trial types. Another advantage is that the template-ICN dual regression method allows for the study of connectivity across groups and tasks in a standardized and unbiased way, which is crucial for studies involving comparisons between clinical and non-clinical samples. Using template ICNs should increase reproducibility of effects and comparability across studies, due to the independence of the ICN templates in reference to the data under study.

Despite a number of methodological strengths, some limitations should be mentioned. In this study, we pooled data from different scanning sites which might have introduces some unmodeled variance. However, we were careful in matching patient group and control group on site characteristics, and ensured that clinical differences did not occur between patients scanned at different locations. Moreover, we added variations in scanning site to our model, and results did not differ from the model where site was not added (post-hoc). Second, the NEO-FFI was not administered at the day of scanning, but on average, 2 months before during the NESDA baseline measurement. However, increasing the time between two measures will tend to decrease the correlation between them, with larger decreases for less reliable measures, thus once again leading if anything to an underestimate of effects. Nevertheless, the administration of the NEO-FFI and a formal measure of positive and negative affect (for example the PANAS; [@bb0180]) and an additional measurement of anhedonia on the day of scanning would be preferable in future studies to maximize sensitivity.

In this study, we have demonstrated, using an unbiased whole-brain functional connectivity approach, decreased connectivity of medial prefrontal regions and ventral subcortical and paralimbic regions in MDD during the execution of an emotional word evaluation task with a distributed salience network. Connectivity of these regions correlated specifically with a propensity to engage in behavior that enhances positive affect, and not with negative affect. We therefore propose that this inability to effectively regulate positive mood states may constitute a second path that contributes to getting 'stuck in the rut' ([@bb0005]). Future studies should test this hypothesis, in addition to investigating the specificity and generalizability of our results to different MDD sub-samples and different tasks. Given the power of this technique to compare distributed patterns of connectivity in an unbiased way, future studies should also examine treatment-related changes of connectivity with the salience network, specifically treatments probing positive affect.
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![Salience network across patients and controls and between group differences.\
a) Mean component across patients and controls together; b) differences between MDD and HC within the salience network showing decreased medial PFC, caudate nucleus, and nucleus accumbens connectivity in the MDD group. Results are displayed at *p* \< .05, family wise error corrected.t \> 2.3. Blue circles highlight lower connectivity in the orbitofrontal cortex (OFC), the yellow circles highlight lower connectivity of the nucleus accumbens (NAcc), and the green circles highlight lower connectivity in the medial prefrontal cortex (medPFC) with the salience network in MDD patients compared with controls; Right figures: mean and 95% confidence interval plots showing the mean connectivity strength in the OFC (upper plot), NAcc (middle plot), and medPFC (bottom plot).](gr1){#f0005}

###### 

Sample characteristics.

                                                 MDD (n = 25)   HC(n = 25)     Between-group statistics                  
  --------------------------- ------------------ -------------- -------------- -------------------------- ------ ------- ---------
  Female                      n                  16             17             .09                                       .78
  AMC/LUMC/UMCG               n                  8/10/7         8/10/7         .00                                       1
  Age                         Years; mean (SD)   33.9 (9.9)     37.2 (10)                                        1.39    .24
  Education                   Years; mean (SD)   12.9 (2.6)     13.8 (2.3)                                       1.31    .26
  Recurrent MDD               N                  15             --                                                       --
  Age of onset                Years; mean (SD)   25 (11)        --                                                       --
  MADRS                       Mean (SD)          14.4 (10.2)    .9 (1.7)                                  60             \< .001
  Range                       0--33              0--6                                                            --      
  IDS_T2                      Mean (SD)          19.2 (11.9)    3.8 (3.3)                                 62             \< .001
  Range                       2--39              0--11                                                           --      
  IDS_T1                      Mean (SD)          28.5 (10.5)    5.3 (2.8)                                 38.5           \< .001
  Range                       2--47              0.10                                                            --      
  BAI                         Mean (SD)          8.5 (7)        2.3 (2.2)                                 107            \< .001
  Range                       0--26              0--8                                                            --      
  VAS                         Mean (SD)          24.8 (20.4)    24 (22.3)                                 293            .89
  Range                       0--65              0--80                                                           --      
  \# volumes                  Mean (SD)          168.8 (18.8)   163.9 (22.3)                                     .69     .41
  Range                       128--207           138--240                                                        --      
                                                                                                                         
  *Classification behavior*                                                                                              
  \# words_pos                Mean (SD)          38.5 (10.5)    45.3 (9.5)                                       6.08    .02
  \# words_neg                Mean (SD)          40 (2.5)       40.1 (6.4)                                       .01     .93
  \# words_neu                Mean (SD)          47.1 (11.0)    39.2 (9.6)                                       7.22    .01
  rt pos                      Sec; mean (SD)     1.52 (.33)     1.36 (.28)                                       3.18    .08
  rt neg                      Sec; mean (SD)     1.28 (.27)     1.27 (.44)                                       .01     .93
  rt neu                      Sec; mean (SD)     1.66 (.39)     1.55 (.36)                                       .96     .33
                                                                                                                         
  *NEO-FFI score s*                                                                                                      
  Extraversion                Mean (SD)          34 (7.3)       42.9 (6.5)                                       20.81   \< .001
  Neuroticism                 Mean (SD)          40.4 (8.1)     25 (4.3)                                         70.72   \< .001
  Openness                    Mean (SD)          32.4 (5.7)     31.7 (4.8)                                       .23     .63
  Conscientiousness           Mean (SD)          35.2 (7.5)     41.8 (3.9)                                       14.98   \< .001
  Agreeableness               Mean (SD)          42 (4.8)       45.6 (5)                                         6.39    .02

MDD: Major Depressive Disorder; HC: healthy controls; AMC: Academic Medical Center, University of Amsterdam; LUMC: Leiden University Medical Center; UMCG: University Medical Center Groningen; MADRS: Montgomery Åsberg Rating Scale; IDS: Inventory of Depressive Symptomatology; BAI: Beck Anxiety Inventory; VAS: Visual Analogue Scale; T1: time of the Netherlands Study of Depression and Anxiety baseline interview; T2: time of Magnetic Resonance Imaging session; \# volumes: number of volumes acquired during the word classification task; \# words_pos/neg/neu: number of words classified as positive, negative, or neutral; rt pos/neg/neu; response time of classifying positive/negative/neutral words; U: Mann--Whitney U non-parametric test statistic; χ^2^: chi-square test statistic; F: one-way ANOVA statistic.

###### 

Effect of diagnosis on connectivity with the salience network: MDD \< HC.

      Center of gravity (MNI)                                                                 
  --- -------------------------------------------------------------- ------ ---- ------ ----- ------
  R   Orbitofrontal cortex, extending into caudate nucleus           15     22   − 2    131   2.83
  L   Nucleus accumbens                                              − 12   22   − 8    68    2.51
  R   Medial prefrontal gyrus, frontal poles                         7      59   5      66    2.60
  R   Frontal pole/ventrolateral prefrontal gyrus                    22     50   − 11   7     2.34
  L   Medial/superior prefrontal gyrus                               − 20   45   − 1    3     2.65
  R   Ventral caudate nucleus                                        8      20   − 2    1     2.56
  R   Putamen                                                        20     12   − 6    1     2.35
  R   Medial prefrontal gyrus, subgenual anterior cingulate cortex   4      20   − 18   1     2.33

Total cluster showing decreased connectivity in MDD as compared to healthy controls. Coordinates indicate center of sub-clusters. Location: hemisphere; L = left hemisphere; R = right hemisphere; MNI: Montreal Neurological Institute coordinate system. Results are reported at *p* \< .05, family wise error corrected for multiple comparisons using permutation tests (\# permutations = 5000) of cluster-mass (voxelwise threshold: t = 2.3). Voxel size: 4 × 4 × 4 mm.

[^1]: M.J. van Tol had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
